Aktieägarna i Biocrine AB kallas härmed till årsstämma tisdagen den 22 juni 2021 kl 13:00 på Mäster Samuelsgatan 42, våning 10, Stockholm. Avstämningsdag: 2021-06-14 Sista anmälningsdag: 2021-06-18 För att minska risken för smittspridning kommer årsstämman 2021 att hållas kort och formell. Om möjlighet ges kommer aktieägarna att senare inbjudas till ett längre informationsmöte i …
Professor P-O Berggren and his research groups run an impressive list of scientific projects outside those commercialized by Biocrine. The research groups also participate in projects conducted by other groups. In most cases, all these projects result in successful scientific publications. Here is a list of publications generated since 2013: The Eye as a Transplantation Site …
Intake of a high-fat diet leads to an increased risk for obesity, type 2 diabetes, cardiovascular diseases and fatty liver. A study in mice from Karolinska Institutet shows that it is possible to eliminate the deleterious effects of a high-fat diet by lowering the levels of apolipoprotein CIII (apoCIII), a key regulator of lipid metabolism. …
Newly published article in Nano Letters about a novel technique to monitor intraocular pressure. Access to the abstract of this article is found HERE.
Newly published article in Scientific Reports (www.nature.com/scientificreports) about the development of a novel platform for intravital 3D imaging of RT2 tumours to facilitate real-time studies of cancer progression. Full access to article is found HERE.
As has recently been published on the Karolinska Institutet in Sweden’s website, professor Per-Olof Berggren and his colleagues have brought new insight into the role of the delta cells within the islet of Langerhans and how they may affect glucose homeostasis. Read more: Press release in English Nature Communications volume 10, Article number: 3700 (2019) Nya fynd förklarar indirekt …
On the web-site of Karolinska Institutet, there is a recent press release regarding a study published in Diabetologia, the scientific journal of the European Association for the Study of Diabetes (EASD). The leader of the study is professor Per-Olof Berggren. Read more: Press release in English Diabetologia 2019, Online ISSN 1432-0428 Transplanterade celler avslöjar tidiga …
On the web-site of Karolinska Institutet, there is recent press release about professor Per-Olof Berggren being awarded the ERC Advanced Grant, one of the most prestigious funding programmes for research in Europe. Per-Olof Berggren, professor of experimental endocrinology at Karolinska Institutet, is now awarded this grant for the second time. Read more: Press release in English …
On the web-site of Karolinska Institutet, there is recent post regarding a new publication in the scientific journal Diabetologia, presenting results from a study of transplanted pancreatic islets in diabetic animals. Read more: 1. Press release from Karolinska Institutet: Short anti-rejection therapy protects transplants in diabetic animals. 2019-02-01. 2. Press release från Karolinska Institutet …
Att Per-Olof Berggren, professor i experimentell endokrinologi vid Institutionen för molekylär medicin och kirurgi, har blivit invald i the American Academy of Arts and Sciences” står att läsa om i en pressrelease på Karolinska Institutets hemsida. Läs mera / Read more: Pressrelease på svenska Link in English American Academy of Arts and Sciences Elects 228 …